Cesca Therapeutics Inc. Archives

Cesca Therapeutics Inc. (NASDAQ:KOOL) Issues Favorable 40-Month Follow-Up Results Of SurgWerks Feasibility Study

Cesca Therapeutics Inc. (NASDAQ:KOOL) has disclosed on Wednesday 40-month follow-up results of its feasibility study evaluating SurgWerks for the treatment of late-stage, no-option critical limb […]

Trending Stocks: Dynavax Technologies Corporation (NASDAQ:DVAX), Cesca Therapeutics Inc. (NASDAQ:KOOL), F5 Networks (NASDAQ:FFIV)

Boston, MA 10/14/2014 (wallstreetpr) – Dynavax Technologies Corporation (NASDAQ:DVAX) announced on 13th October that it had initiated phase 1/2 clinical trials of its drug candidate […]

Wall Street PR